Dr. Lal PathLabs

Dr. Lal PathLabs EBIT

The EBIT of Dr. Lal PathLabs (LALPATHLAB.NS) as of Oct 24, 2026 is 6.21 B INR. In the previous year, EBIT was 6.47 B INR — a change of -4.08% (lower).

EBIT

6.21 BINR

YoY

-4.08%

Last updated:

In 2026, Dr. Lal PathLabs's EBIT was 6.21 B INR, a -4.08% increase from the 6.47 B INR EBIT recorded in the previous year.

The Dr. Lal PathLabs EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
3.51 B INR
Jan 1, 2024
5.35 B INR
Jan 1, 2025
6.47 B INR
Jan 1, 2026
6.21 B INR
Jan 1, 2027 (e)
8.77 B INR
Jan 1, 2028 (e)
10.29 B INR
Jan 1, 2029 (e)
11.91 B INR
Jan 1, 2030 (e)
0.00 INR
The Dr. Lal PathLabs EBIT history
YEAREBITYoY
est0.00INR-100.00%
est11.91 BINR+15.78%
est10.29 BINR+17.35%
est8.77 BINR+41.27%
6.21 BINR-4.08%
6.47 BINR+21.00%
5.35 BINR+52.17%
3.51 BINR-52.32%
7.37 BINR+79.60%
4.10 BINR-7.78%
4.45 BINR+7.89%
4.13 BINR+13.75%
3.63 BINR+14.97%
3.15 BINR+73.05%
1.82 BINR+42.43%
1.28 BINR+12.51%
1.14 BINR+45.02%
784.39 MINR+15.46%
679.39 MINR+53.65%
442.17 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dr. Lal PathLabs Revenue

Dr. Lal PathLabs Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
20.17 B INR
3.51 B INR
2.39 B INR
Jan 1, 2024
22.27 B INR
5.35 B INR
3.58 B INR
Jan 1, 2025
24.61 B INR
6.47 B INR
4.87 B INR
Jan 1, 2026
27.63 B INR
6.21 B INR
5.05 B INR
Jan 1, 2027 (e)
32.08 B INR
8.77 B INR
6.20 B INR
Jan 1, 2028 (e)
36.66 B INR
10.29 B INR
7.32 B INR
Jan 1, 2029 (e)
41.51 B INR
11.91 B INR
8.78 B INR
Jan 1, 2030 (e)
50.33 B INR
0.00 INR
0.00 INR

Dr. Lal PathLabs Margins

Dr. Lal PathLabs stock margins

The Dr. Lal PathLabs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Dr. Lal PathLabs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Dr. Lal PathLabs.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
63.84 %
17.43 %
11.84 %
Jan 1, 2024
65.67 %
24.02 %
16.07 %
Jan 1, 2025
66.56 %
26.29 %
19.79 %
Jan 1, 2026
42.01 %
22.47 %
18.27 %
Jan 1, 2027 (e)
42.01 %
27.33 %
19.33 %
Jan 1, 2028 (e)
42.01 %
28.07 %
19.96 %
Jan 1, 2029 (e)
42.01 %
28.70 %
21.15 %
Jan 1, 2030 (e)
42.01 %
0.00 %
0.00 %

Dr. Lal PathLabs Stock analysis

What does Dr. Lal PathLabs do? Dr. Lal PathLabs Ltd is a leading diagnostic company in India, offering a wide range of tests and services. The company was founded in 1949 by Dr. S.K. Lal in Delhi and has since expanded its services throughout India. Business Model: The business model of Dr. Lal PathLabs Ltd is based on offering diagnostic test packages for various diseases and disorders. Customers can choose from different test packages tailored to their specific needs. The company utilizes state-of-the-art technology and equipment in its laboratories to deliver accurate results. Another important pillar of the business model is close collaboration with doctors and clinics to improve customer care and provide comprehensive medical services. Company History: Dr. Lal PathLabs Ltd began its journey in 1949 in Delhi, India, when Dr. S.K. Lal founded the company. It was one of the few private laboratories capable of conducting diagnostic tests and was a pioneer in developing modern technology and equipment to support the tests. Over the years, the company has expanded its operations and services and is now one of the leading diagnostic companies in India. It is known for its precise test results, excellent customer care, and innovative technology. Segments: Dr. Lal PathLabs Ltd offers a wide range of diagnostic tests and services. The various segments covered by the company include: 1. Clinical Pathology: This segment covers a wide range of tests targeting the customers' health condition. They include blood tests, urine and stool tests, hormone tests, diabetes checks, pregnancy tests, and more. 2. Microbiology: This segment deals with the identification of pathogens such as bacteria, viruses, fungi, and parasites found in tests of body fluids and tissue samples. 3. Histology: This segment covers the identification of tissue samples and cells. It is used in the diagnosis of cancer, thyroid disorders, and other diseases. 4. Immunology: Tests are conducted based on antibodies to diagnose autoimmune diseases, infectious diseases, and allergies. 5. Genetics: This segment deals with the diagnosis of genetic diseases and genetic testing for disease prevention. Products: Dr. Lal PathLabs Ltd offers a wide range of diagnostic test packages customized to individual customer needs. Some of the key test packages include: 1. Pro 1: This test package provides a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, and uric acid. 2. Essential Health Checkup: This test package is designed for checking heart health and includes tests such as electrocardiogram (EKG), lipid profile, and complete blood count. 3. Diabetic Profile: This test package is specifically designed for diabetics and includes tests such as HbA1c, kidney function tests, and lipid profile. 4. Comprehensive Health Checkup: This test package offers a comprehensive evaluation of all key parameters, including cholesterol, blood pressure, blood sugar, and uric acid. Dr. Lal PathLabs Ltd has established itself as a leading diagnostic company in India and is known for its high accuracy in test results and innovative technology. The company is committed to improving medical care and works closely with doctors and clinics to provide comprehensive medical services. Dr. Lal PathLabs is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Dr. Lal PathLabs's EBIT

Dr. Lal PathLabs's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Dr. Lal PathLabs's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Dr. Lal PathLabs's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Dr. Lal PathLabs’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Dr. Lal PathLabs stock

EBIT of Dr. Lal PathLabs is 6.21 B INR in 2026.

EBIT of Dr. Lal PathLabs changed from 6.47 B INR to 6.21 B INR, representing a -4.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Dr. Lal PathLabs since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Dr. Lal PathLabs historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Dr. Lal PathLabs

All Key Metrics — Dr. Lal PathLabs